t
Clean Power Hydrogen plc (CPH2) announced on 2 July 2026 that it would post a Circular and Notice of General Meeting to shareholders today. The General Meeting, concerning a proposed fundraising announced on 1 July 2026, is scheduled for Monday 20 July 2026 at 11:00 am.
| Date | 2 Jul 2026 |
| Time | 17:30:00 |
| Category | AGMs and other meetings |
| ID | 8706K |
2 July 2026
Clean Power Hydrogen plc
("CPH2", the "Company" or the "Group")
Posting of Notice of General Meeting
Clean Power Hydrogen plc (AIM: CPH2), the UK-based green hydrogen technology company, announces that it will today post a Circular and Notice of General Meeting to shareholders in relation to the proposed fundraising announced on 1 July 2026.
The General Meeting will be held at the offices of K&L Gates LLP, One New Change, London EC4M 9AF on Monday 20 July 2026 at 11.00 am. The Notice of General Meeting has been posted to shareholders and is available on the Company's website at https://www.cph2.com/investors/circulars-documents/.
ENDS
For more information, please contact:
|
Clean Power Hydrogen plc |
+44 (0)130 232 8075 |
|
Richard Scott, Chief Executive Officer Elect |
|
|
James Hobson, Chief Financial Officer |
|
|
|
|
|
Cavendish Capital Markets Limited - NOMAD & Joint Broker |
|
|
Neil McDonald |
+44 (0)131 220 9771 |
|
Peter Lynch |
+44 (0)131 220 9772 |
|
Hanna Leijonmarck |
+44 (0)20 7908 6029 |
|
|
|
|
Turner Pope Investments (TPI) Ltd - Joint Broker |
|
|
Andy Thacker |
+44 (0)20 3657 0050 |
|
Guy McDougall |
|
Background on CPH2
CPH2 is the holding company of Clean Power Hydrogen Group Limited which has a decade of dedicated research and product development experience that has delivered global patents in breakthrough hydrogen and oxygen production technology. The Group's strategic objective is to deliver the lowest lifetime LCOH in the market in relation to the production of hydrogen for the growing electrolysis or decentralised markets and alternative energy markets. CPH2 is listed on the AIM market and trades under the ticker AIM:CPH2.
For more information: https://www.cph2.com